Gerber Kawasaki Wealth & Investment Management Absci Corp Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.58 - $3.41 $19,928 - $43,010	-12,613 Reduced 55.78%	10,000 $17,000
Q4 2022 Feb 08, 2023	SELL	$2.0 - $3.58 $80,000 - $143,200	-40,000 Reduced 63.88%	22,613 $47,000
Q1 2022 May 12, 2022	BUY	$5.87 - $9.46 $367,538 - $592,318	62,613 New	62,613 $527,000

Others Institutions Holding ABSI

# of Institutions

135

Shares Held

61.6M

Call Options Held

255K

Put Options Held

93.6K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.27M
Shares

$30.6 Million
0.19% of portfolio
Redmile Group, LLC San Francisco, CA

8.25M
Shares

$30.5 Million
2.06% of portfolio
Fred Alger Management, LLC New York, NY

7.57M
Shares

$28 Million
0.15% of portfolio
Black Rock Inc. New York, NY

5.34M
Shares

$19.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.94M
Shares

$18.3 Million
0.0% of portfolio

View Full List

About Absci Corp

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $344M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

More about ABSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account